Skip to main content

Automotive Data Monetization Market Report-Size Set for Rapid Growth and Trend by 2030

 Data monetization is presently at an early stage of adoption, it has been made an important part of the strategy in many high-performing and fast-growing companies, especially from retail, services, automotive, finance, and banking sectors. With the rising number of autonomous vehicles on roads, a massive amount of data is being generated due to the growing count of sensors connecting these vehicles to each other and to external infrastructures providing information on geolocation, vehicle performance, driver behavior, biometrics along with other data, from these central intelligence-driven machines. This car-generated data has the potential of being turned into valuable products and services by the evolving automotive ecosystem.

The collection of automotive-generated data has been paced at a reasonable rate, yet the monetization of this automotive data is still in its nascent stage. The growth of the overall revenue pool from car data monetization at a global scale comes from the ability of the market players to develop products that create revenue, reduce costs, and ensure safety and security by using the data generated by cars, drivers, and mobility systems. These promising aspects lure both automotive and non-automotive companies to the financial benefit of the available automotive data pool. Original equipment manufacturers (OEMs) have themselves been investigating data monetization increasingly but have been traditionally reluctant in sharing the data with third parties. However, they are gradually heightening the sharing of vehicle-generated data with the participants in-car data markets and creating new revenue streams for themselves.

The global automotive data monetization market is estimated to grow with a CAGR of 63.67% during 2020-2030 and reach a market size of $20.34 Billion by the end of 2030. 

Market Segmentation


•    End User – Insurance, Government, Predictive Maintenance, and Mobility as a Service

•    By Deployment Type- Cloud, On Premise

•    Type – Direct, Indirect


Regional Segmentation

•    North America - U.S., Canada, and Mexico

•    Europe – Germany, Italy, France, and Rest-of-Europe

•    Asia-Pacific and Japan (APJ) – Japan, South Korea, and Rest-of-APJ

•    U.K.

•    China

•    Rest-of-the-World


Growth Drivers

•    Rise in Vehicle Connectivity Fueling the Demand for Monetizing Data

•    New Service Opportunities for Automotive OEMs

•    Need for Creating Customer Value Proposition


Market Challenges

•    Cybersecurity Risk

•    Legal Challenges of Personal Data Monetization

•    Issues with Data Quality


Market Opportunities

•    Use of Blockchain


Key Companies Profiled

Continental AG, Wejo Limited, Otonomo, Xevo, IBM, Oracle, Tesla, Harman International, AWS, Microsoft Corporation, Tech Mahindra Limited, SMARTO, Vinli Inc, Caruso GmbH, and The Floow Limited.

Request a Sample - https://bisresearch.com/requestsample?id=1094&type=download

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...
Post a Comment
Read more

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...
Post a Comment
Read more